paxilline has been researched along with imatinib mesylate in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Li, QF; Tang, DD; Wang, R | 1 |
Grebeňová, D; Halada, P; Hrkal, Z; Kuželová, K; Pavlásková, K; Pluskalová, M | 1 |
Chikh, A; Denti, L; Fantin, A; Lampropoulou, A; Raimondi, C; Ruhrberg, C | 1 |
Bálint, Z; Dahal, BK; Kwapiszewska, G; Murmann, K; Schermuly, RT; Seeger, W; Veith, C; Weissmann, N; Wygrecka, M; Zakrzewicz, D | 1 |
Barrett, A; Brandner, S; Evans, IM; Frankel, P; Frolov, A; Li, N; Lockwood, N; Paliashvili, K; Sidlauskas, K; Zachary, IC | 1 |
Bleher, R; Dravid, VP; Dudek, SM; Garcia, JGN; Shekhawat, GS; Wang, L; Wang, X | 1 |
6 other study(ies) available for paxilline and imatinib mesylate
Article | Year |
---|---|
Abl knockout differentially affects p130 Crk-associated substrate, vinculin, and paxillin in blood vessels of mice.
Topics: Actins; Animals; Aorta; Benzamides; Blood Pressure; Crk-Associated Substrate Protein; Imatinib Mesylate; Male; Mesenteric Arteries; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myosin Light Chains; Paxillin; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Vasoconstriction; Vinculin | 2009 |
Changes in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Electrophoresis, Gel, Two-Dimensional; Fibronectins; Flow Cytometry; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Microscopy, Fluorescence; Paxillin; Piperazines; Pyrimidines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tropomyosin | 2010 |
Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
Topics: Animals; Benzamides; Cell Adhesion; Cell Movement; Cells, Cultured; Endothelial Cells; Enzyme Activation; Fibronectins; Humans; Imatinib Mesylate; Immunoblotting; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Confocal; Neovascularization, Physiologic; Neuropilin-1; Paxillin; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Retinal Neovascularization; RNA Interference; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
Topics: Active Transport, Cell Nucleus; Animals; Antihypertensive Agents; Apoptosis; Becaplermin; Benzamides; Cell Adhesion; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Paxillin; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; Signal Transduction; Time Factors; Transfection; Tyrosine; Vascular Remodeling | 2014 |
Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling.
Topics: Adaptor Proteins, Signal Transducing; Cell Line, Tumor; Cell Movement; Crk-Associated Substrate Protein; Discoidin Domain Receptor 1; Focal Adhesion Kinase 1; Glioblastoma; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasm Invasiveness; Paxillin; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; Signal Transduction | 2016 |
Imatinib Alters Agonists-mediated Cytoskeletal Biomechanics in Lung Endothelium.
Topics: Antigens, CD; Cadherins; Cells, Cultured; Cortactin; Cytoskeleton; Endothelium, Vascular; Fluorescent Antibody Technique; Humans; Imatinib Mesylate; Lysophospholipids; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Paxillin; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pulmonary Artery; Sphingosine | 2017 |